FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...